Mar 1, 2013

Mainstream Science tries to connect depression with decreased effectiveness of the Shingles Vaccination

Vaccines are Toxic
Via: NewsMedical
Results from a new study published in Clinical Infectious Diseases suggest a link between untreated depression in older adults and decreased effectiveness of the herpes zoster, or shingles, vaccine. Older adults are known to be at risk for shingles, a painful condition caused by the reactivation of the varicella-zoster virus, and more than a million new cases occur each year in the U.S. The vaccine boosts cell-mediated immunity to the virus and can decrease the incidence and severity of the condition.

In a two-year study, led by Michael Irwin, MD, at the University of California-Los Angeles, researchers measured the immune responses to shingles vaccination among 40 subjects aged 60 or older with a major depressive disorder and compared these responses to similar levels in 52 control patients matched by age and gender. Measurements were taken at baseline, and then 6 weeks, 1 year, and 2 years after the patients received the shingles vaccine or a placebo.

Depressed patients not being treated with antidepressants (selective serotonin uptake inhibitors) had lower cell-mediated immunity to the varicella-zoster virus-and were less able to respond to the shingles vaccine-compared with patients who were not depressed or who were depressed but were receiving treatment with antidepressants, the researchers found.

The findings suggest that patients with untreated depression were "poorly protected by shingles vaccination," said Dr. Irwin. Depression treatment, on the other hand, boosted cell-mediated immunity and increased the effectiveness of the vaccine among those studied, even when the treatment did not lessen depression symptoms, the researchers found. Treating depression, noted Dr. Irwin, appeared to "normalize the immune response to the zoster vaccine" in the study.

Feb 24, 2013

Miami Man Contracts Guillain-Barré Syndrome, Nearly Dies After Getting Flu Shot

Avoid the Vaccinators Lancet

Via: Miami News
Three months ago, Michael Stec could bench-press 275 pounds. Now the 56-year-old struggles to walk, gripping tightly to the parallel bars at Mercy Hospital, his legs buckling underneath him like broken stilts.
Most people never know how they get sick. But Stec says he can pinpoint the exact moment. He even has a receipt for it: a $32 influenza vaccine from a local CVS Pharmacy.

"Something is wrong with this flu shot," he says from his hospital bed, his tracheotomy scar still visible.

Stec, who asked to go by his wife's maiden name because he works for a government agency that hasn't authorized him to speak, was diagnosed with a rare neurological disease called Guillain-Barré syndrome (GBS) November 11 -- eight days after receiving the flu shot.
"At first I felt a tingling in my fingers and toes, but I didn't think anything of it," he says. By the end of the day, however, he knew something was seriously wrong.

"The next morning he couldn't walk," says his wife, Isabelle. "He was staggering around like he was drunk."

When Stec began having trouble breathing, she dialed 911. Stec passed out shortly after paramedics arrived. Stec's diaphragm shut down an hour after he was rushed to Mercy. Doctors cut a hole in his throat and put him on a breathing machine. Then his nervous system went haywire. Several times Isabelle thought he would die.

Three months later, Stec is recovering. Last week he took his first, shaky step. His outrage, however, is strong. "I cannot believe that the U.S. government would allow such a thing to be on the market," he says.

This season has, in fact, seen unprecedented advertising for flu vaccines, which are a booming industry in the United States. Both the Centers for Disease Control and Prevention (CDC) and CVS Pharmacy do warn people of the risk of contracting GBS. But the warning is vaguely written in fine print: "If there is a risk of GBS from current flu vaccines, it would be no more than one or two cases per million people vaccinated."

"CVS/pharmacy is committed to safe vaccination practices," a spokesman says. "The low risk associated with vaccinations and GBS is in no way related to CVS/pharmacy specifically."

The CDC says the minute risk of GBS is worth it. "You have to look at the whole package of risk and benefit," says Dr. Claudia Vellozzi, deputy director of the CDC's Immunization Safety Office. The flu kills an average of 36,000 Americans per year, she points out, and contracting GBS from a vaccine is extremely rare.

Stec questions that logic, however. "You can risk getting paralyzed, or you can risk a couple of weeks with the sniffles," he says. "How can you put this in comparison?"

He believes there are more victims like him than the CDC and Big Pharma admit. "They say the chances are one in a million," Stec says. "I think there are more and they are hiding the statistics."

Stec says it will be months before he can return to work. He may never fully recover and is considering filing a lawsuit in "vaccine court."
"This is agony," he says. "People should know that before getting the shot."

Four-day-old Baby Dies After Vaccination

Pre-traumatic stress disorder
Theni, Tamil Nadu: A four-day-old baby girl died after allegedly being administered hepatitis vaccine at the Government hospital in Theni, in Tamil Nadu, officials said today. The baby's parents in a complaint to the Government College dean Soundararajan said the vaccine was given yesterday and the infant died within half-an-hour. The spot where the vaccine was injected turned pale and the baby died, the parents said. Officials are verifying if the vaccine was properly refrigerated or had expired.
Experimental Vaccines Homepage